New Kisqali Combination Joins Verzenios In England’s Cancer Drugs Fund

 
• By Neena Brizmohun
  
Funding
Novartis has secured reimbursement for Kisqali in England • Source: Shutterstock

More from Market Access

More from Pink Sheet